G01N 2800/162
Conjunctival disorders
Official title: Conjunctival disorders, e.g. conjunctivitis
G01N2800/162 (Conjunctival disorders) appears on 13 US grants and 34 published applications in this corpus.
Search patents in G01N- Granted patents
- 13
- Published applications
- 34
- Assignees
- 13
- Inventors
- 42
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 2 | 4 |
| 2014 | 1 | 0 |
| 2015 | 3 | 3 |
| 2016 | 0 | 1 |
| 2017 | 0 | 3 |
| 2018 | 0 | 1 |
| 2019 | 2 | 2 |
| 2020 | 2 | 5 |
| 2021 | 0 | 3 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for changing condition of eyelid of hairless animal30 Dec 2025US 12,510,536 B2Santen Pharmaceutical Co., Ltd.
- Method for measuring tear constituents in a tear sample15 Nov 2022US 11,499,980 B2Diagnostear, Ltd.
- Method for visualization of conjunctival cells using fluoroquinolone antibiotics and method for diagnosis of ocular lesions using the same8 Dec 2020US 10,859,498 B2Postech Academy-Industry Foundation
- Method for measuring tear constituents in a tear sample7 Jan 2020US 10,527,628 B2Diagnostear, Ltd.
- Compositions and methods for treating eye infections and disease27 Aug 2019US 10,393,755 B2University of Virginia Patent Foundation
- Cd59 for inhibiting inflammasome activation13 Aug 2026US 2026/0232845 A1Trustees of Tufts College
- Point of Care Device for Detection of Analytes in Tear Film and Other Biological Samples14 Nov 2024US 2024/0377391 A1InnSight Technology, Inc.
- Compositions and methods for treating eye infections and disease11 Jul 2024US 2024/0230669 A1University of Virginia Patent Foundation
- Method for measuring tear constituents in a tear sample16 Mar 2023US 2023/0079291 A1Diagnostear, Ltd.
- Compositions and methods for treating eye infections and disease29 Jul 2021US 2021/0231684 A1University of Virginia Patent Foundation
Most cited
By later US patents
- Biomarker normalization22US 9,217,702 B2The Regents of the University of California · 2015
- Therapeutic target and diagnostic marker for asthma and related conditions7US 8,409,565 B22013
- Biomarker normalization6US 7,905,134 B2The Regents of the University of California · 2011
- Biomarker normalization2US 9,217,701 B2The Regents of the University of California · 2015
- Method for measuring tear constituents in a tear sample1US 10,527,628 B2Diagnostear, Ltd. · 2020